Latest News

Image description

Actavis, Adamas approved for Namzaric

Actavis and Adamas Pharmaceuticals last week announced that the Food and Drug Administration approved Namzaric. According to the companies, the drug is used to treat moderate to severe dementia of the Alzheimer's type in patients stablized on memantine hydrochloride and donepezil hydrochloride.

 

Image description

Study: Many shoppers plan to buy gift cards this holiday

Spend on prepaid gift cards is on the rise this holiday season, as a significant majority (70%) of shoppers plan to purchase gift cards this season, according to an interim holiday spending report released by Stored Value Solutions, a provider of gift cards and stored-value services.

Image description

FDA approves Teva's Granix Injection for self-administration

Teva Pharmaceutical today announced that the Food and Drug Administration has approved Granix (tbo-filgrastim) Injection for self-administration by patients and caregivers. With the approval of this additional administration option, physicians will soon have the flexibility to prescribe Granix for either in-office or at home use.